Mtp publiczne
[search 0]
Więcej

Download the App!

show episodes
 
歡迎來到音樂療天室,一同來聊聊工作生活上說不出口的心聲吧! 心聲?新聲?還是新生? 一個總是被誤認為音樂老師的音樂治療師淑雯,遇上從小學音樂,卻常常不誤正業的音樂老師佳佳,這兩個常被大眾混為一談的職業,在工作上會遇到多少疑難雜症呢?快進來音樂療天室,聽聽兩人的真實心聲吧! 歡迎到apple podcast 留言評分五顆星 來信合作與即時互動 mt.podcast2020@gmail.com Instagram/Facebook 搜尋【音樂療天室】 Powered by Firstory Hosting
 
Loading …
show series
 
It’s World Antimicrobial Awareness Week and this year’s theme is “Preventing Antimicrobial Resistance Together”. We chat to Bugworks, a clinical stage pharmaceutical company, headquartered in the US, with subsidiaries in India and Australia, currently developing novel antibacterials and immunotherapies. Bugworks’ Co-founder and Chief Executive Offi…
 
MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia’s outstanding innovative medical technologies and capabilities to the world’s largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking ev…
 
MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia’s outstanding innovative medical technologies and capabilities to the world’s largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking ev…
 
CSIRO’s year-round Kick-Start program has helped over 200 early-stage start-ups and small businesses pursue R&D activities by providing access to CSIRO research and capability. This includes help with articulating a company’s research question, connecting businesses with relevant CSIRO researchers and fifty per cent matched funding support to impro…
 
Inventia Skin is a Sydney-based start-up on a mission to revolutionise wound repair by developing Ligō, a skin printing robot. It delivers rapid and precise regenerative cellular therapy products directly onto a wound and could help to treat difficult to heal skin burns. A number of partners - high profile scientists and physicians - are lending th…
 
Back in May 2019, MTPConnect launched the Biomedical Translation Bridge (BTB) program, a $22.3 million initiative of the Medical Research Future Fund, supporting the translation of new therapies, technologies and medical devices through to the proof-of-concept stage. In a first for Australia, it did that by pairing funded projects with industry men…
 
MTPConnect is delivering the MRFF-funded $19.75 million Clinical Translation and Commercialisation Medtech (CTCM) program to support the development of home-grown medical devices. The program has opened its second and final funding round calling for applications from Australian small to medium-sized enterprises (SMEs) developing medical device proj…
 
Back in May 2019, MTPConnect launched the Biomedical Translation Bridge (BTB) program, a $22.3 million initiative of the Medical Research Future Fund, supporting the translation of new therapies, technologies and medical devices through to the proof-of-concept stage. In a first for Australia, it did that by pairing funded projects with industry men…
 
The Australian Centre for Health Services Innovation (AusHSI) is a leading health services research centre, based at the Queensland University of Technology (QUT) within the Faculty of Health. The Centre is working with our Targeted Translation Research Accelerator Program providing support and mentoring to TTRA applicants and awardees with standal…
 
Professor Marshall is a celebrated vaccination researcher, who has been named the 2022 South Australia Australian of the Year. Her work in vaccinology, public health and infectious diseases at the University of Adelaide’s Robinson Research Institute has focused on protecting babies and children from Meningococcal disease. She led the world’s larges…
 
Antimicrobial resistance (AMR) has been described as a ‘silent pandemic’, and now takes more lives than malaria and HIV globally, and in Australia, over 1,600 deaths were attributed to AMR in 2019. CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership focused on supporting antibacterial re…
 
As new COVID-19 variants are detected in Australia and a wave of COVID cases spike again, researchers at the University of Sydney have teamed up with an international consortium to develop a low-cost variant proof COVID-19 vaccine with the help of US $19.3 million funding from The Coalition for Epidemic Preparedness Innovations. To tell us more abo…
 
Heart attack caused by rupture of unstable plaque in the coronary arteries is the number one cause of death worldwide. Melbourne-based medtech company Nirtek, is using laser technology discovered at the Baker Heart and Diabetes Institute, to develop the first intra-coronary guidewire device for the detection of unstable plaque to prevent heart atta…
 
As the world’s largest Biotech convention, BIO 2022, gets underway in San Diego California after a 2 year hiatus due to pandemic restrictions, MTPConnect’s team is on the ground promoting Australian companies at the Australian Pavilion (led by AusBiotech) and attending various events and meetings. In this pacey compilation, MTPConnect CEO Stuart Di…
 
The last few years have been dominated by the global fight against COVID-19 and research efforts continue in search of new treatments and vaccines to save lives. Melbourne-based Dimerix Bioscience is a clinical-stage biopharmaceutical company investigating a new treatment for respiratory complications as a result of COVID 19 – which was selected fo…
 
Around the world, approximately 16,500 people die from sudden cardiac arrest every day due to delayed access to a defibrillator. We speak with Donovan Casey, co-founder, CEO and Executive chairman of Rapid Response Revival, a Sydney based medical technology startup hoping to improve these odds of survival by developing CellAED - a life-saving porta…
 
Is your startup on a mission to address a major public health challenge? Do you need the know-how, guidance and connections to get investment-ready and rapidly grow? MTPConnect co-hosts Caroline Duell and Dr Duncan Macinnis, Director Stakeholder Engagement for NSW and ACT, look into the unique Health 10X Accelerator delivered by the George Institut…
 
We speak to Robert Yearsley, CEO and co-founder of ARIA Research, a company developing a new medical device - a non-surgical and non-invasive Electronic Vision Aid in the form of a pair of glasses - which enables blind and vision-impaired people to see through sound. ARIA has been developed in collaboration with University of Sydney, University of …
 
In the first face-to-face podcast interview since January 2020, we speak with Dr Mat McGann, co-founder and CEO of Health Horizon, a health innovation tracking and discovery platform - making it easy to follow the progress of medical innovations around the world. MTPConnect supported Health Horizon's development through the Growth Centre Project Fu…
 
The show takes a look at how we can take more great Australian science from the lab bench into the boardroom. And create companies, jobs and products. Joining the podcast is Misha Schubert, Chief Executive Officer at Science & Technology Australia and Professor Mark Hutchinson, the new President at Science & Technology Australia. Science & Technolo…
 
The Clinical Translation and Commercialisation - Medtech (CTCM) program, delivered by MTPConnect, is offered under the 2020 Early Stage Translation and Commercialisation Support Grant of the Medical Research Future Fund's Medical Research Commercialisation Initiative. The $19.75 million CTCM program is targeting Australian small to medium-sized ent…
 
We get an update on the development of Australia’s world-first Bionic Eye System. Similar to Cochlear’s bionic ear, it involves a visual implant to give functional vision to people who’ve lost their sight due to the genetic condition, Retinitis Pigmentosa. The consortium behind this innovation, which has just been granted a Breakthrough Device desi…
 
For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned…
 
Episode 118. Ancient and New: WA’s Cliniface and Lyfe Languages Improving Indigenous Healthcare Through Technology The podcast visits Western Australia to find out how new technology like Artificial Intelligence is being used to improve healthcare for Indigenous Australians and those living in remote communities. Cliniface is delivering the world’s…
 
It’s World Antimicrobial Awareness Week and we are shining a light on Australia’s expertise and innovations to fight superbugs. In this episode, hosts Caroline Duell and Dr Rebecca Tunstall, MTPConnect’s Senior Director of Stakeholder Engagement, catch up with BiomeBank, a company out of South Australia. As Australia's first public stool bank and a…
 
It’s World Antimicrobial Awareness Week 2021 and we are shining a light on Australia’s expertise and innovations to fight superbugs. In this episode we catch up with Recce Pharmaceuticals, a company out of Western Australia that is pioneering the development and commercialisation of a new class of synthetic anti-infectives designed to overcome resi…
 
It’s World Antimicrobial Awareness Week and we are shining a light on Australia’s expertise and innovations to fight antimicrobial resistance (AMR) and superbugs. In this episode, we catch up with LBT Innovations, a groundbreaking South Australian company designing advanced medical technologies that automate culture plate reading and improve medica…
 
It’s World Antimicrobial Awareness Week 2021 and we are shining a light on Australia’s expertise and innovations to fight antimicrobial resistance (AMR) and superbugs. Joining our podcast host Caroline Duell is MTPConnect’s Director of Stakeholder Engagement for Queensland Andrew Bowskill, who is the co-chair of AAMRNet, Australia’s first industry …
 
We catch up with medtech start-up Coviu, the company behind a game-changing video telehealth software that is now being used by 65,000+ health professionals in Australia. Coviu recently took out two awards at the Australian Technologies Competition (ATC), an accelerator program that MTPConnect supports in partnership with the Australian Government’…
 
The Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, supported by the Medical Research Future Fund, is providing a new integrated research program to improve the prevention, diagnosis, treatment and management of diabetes and cardiovascular disease (D&CVD) in Australia. The TTRA is calling for Exp…
 
Dr Maheshi Ramasamy is a Principal Investigator at the Oxford Vaccine Group where she leads on adult clinical vaccine trials including the Oxford AstraZeneca COVID-19 vaccine trials. Dr Ramasamy joins the podcast from the UK to take us through the challenges of developing a successful international clinical trial against the clock during a fast-mov…
 
A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a second-generation COVID-19 vaccine using their proprietary viral-vector vaccine platform technology, in partnership with the University of South Australia. The vaccine candidate is anticipated to be effective against mutant strains of COVID-19. T…
 
GSK Australia has developed the GSK Graduate Researcher Program, with support from MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative. The multinational pharmaceutical company gives PhD postgraduates a 12-month placement assigning them to lead on core projects in areas such as early product development, medical affai…
 
Australian company Synchron has developed a brain chip called the Stentrode that helps people with paralysis communicate by controlling digital devices with their thoughts. The groundbreaking medical device is implanted into the motor cortex without open brain surgery. It has been trialed successfully with several Australian patients and is the fir…
 
Australian MedTech startup, Vantari VR, has developed a virtual reality technology-based on flight simulation for medical training. It’s already being used to teach life-saving medical procedures in several Australian hospitals. The technology is so good it’s attracted funding from one of the world’s largest video game developers! Dr Nishanth (Nish…
 
「音樂療天室」第一季結束啦!!! 回顧資料夾中滿滿的音檔和腳本,想起2020年的這個時刻,佳佳和淑雯才剛剛起步,討論著工作分配及目標設立,互相扶持不放棄的合作這60集,「音樂療天室」的定位和樣貌也漸漸成形了,幸好佳佳和淑雯還有繼續合作挑戰的心,第二季的內容會是什麼呢?邀請大家跟佳佳和淑雯一起期待「音樂療天室」的第二季吧! Powered by Firstory Hosting
 
疫情下的問候語:「你打疫苗了嗎?」(你有黃色小卡嗎?) 疫情期間漫漫長的等待,除了等疫苗等工作之外,2020延期到2021舉辦的東京奧運當然不能錯過囉,好多好多精彩熱血的運動賽事,凝聚電視前的我們等著一場又一場的轉播,不斷測試自己是不是反指標的佳佳和剛剛好遇上羽球金牌戰的淑雯,準備來當不專業的「一日球迷」,歡迎大家一起加入這週的音樂療天室分享聊聊吧! Powered by Firstory Hosting
 
Strep A is a highly contagious bacteria responsible for more than half a million deaths every year and is developing resistance to antibiotics. In Australia, diseases caused by Strep A, such as rheumatic fever and rheumatic heart disease, disproportionately affect Aboriginal and Torres Strait Islander communities. The good news is an Australian led…
 
因為喜歡音樂,選擇踏上這段練琴的旅程,過程中漸漸感受到對未來的迷惘,一個人摸索尋找,拼湊規劃接下來的路,當仲寧揹著小提琴到德國繼續學習音樂時,面對語言的不同、文化的衝擊和異地的生活等等的挑戰,她是如何克服這些在演奏的領域繼續努力呢?邀請大家跟佳佳和淑雯一起來聽聽仲寧分享德國的音樂留學生活吧! Powered by Firstory Hosting
 
關於音樂治療師養成的這個主題,除了之前幾集聊聊英國和美國的訓練之外,這次邀請到佳佳和淑雯的國中同學–珈羽,來節目分享在澳洲墨爾本大學學習音樂治療的過程,以及如何申請到台灣教育部獎學金來補貼一些留學生活的費用,邀請大家一起參與這集國中同學會性質的音樂療天室,聊聊珈羽的留學回憶及課業挑戰吧! 備註:每學期的實習場所安排不同,依照學校的課程要求及因應特殊狀況(如疫情封城或機構內部接洽不適合接受實習生等等)有些微調整 Powered by Firstory Hosting
 
In this episode, we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. You will hear from Colin Denver, CEO of SpeeDx Pty Ltd, an Australian diagnostics company developing t…
 
生活上的支持與陪伴,讓擁有多重角色下的我們得到一些些力量,面對日常中許多不平衡和挑戰,音樂治療師與協同治療師共同帶領的支持性團體,透過音樂接納每位照顧者的疲憊或挫折,在團體動力的運作下,感受每位參與者的理解與茁壯,跟著佳佳和淑雯一起來聽聽,音樂治療師邱婷婷聊聊關於支持性團體的實務面吧! Powered by Firstory Hosting
 
「…原來音樂也可以幫助人…」,這樣的認知和意識,引領著很多人走向音樂治療的學習,拿到音樂治療的文憑後,創造工作機會就是畢業後第一個挑戰,邀請大家一起來聽聽,關於婷婷申請美國音樂治療學位的回憶及成為音樂治療師的感動吧! Powered by Firstory Hosting
 
In this episode, we take you to the launch of our new report into Australia’s Clinical Trials sector held on International Clinical Trials Day in Melbourne. MTPConnect brought together a panel of thought leaders to discuss the importance of clinical trials. Hear insights from our esteemed panel chaired by Dr Dan Grant, MTPConnect's Managing Directo…
 
5月中,疫情升溫三級,出門口罩、酒精、護目鏡或面罩等等,餐廳只能外帶,進店家登記或掃QR-code,市場商店開始分流,這樣的模式已經默默生活快兩個月了,這些日子中,佳佳和淑雯也部份調整現階段的工作安排,邀請大家一起來聊聊疫情期間的無奈及對解封後的期待吧! Powered by Firstory Hosting
 
2015年的八仙塵暴,徹底扭轉思妤的人生跑道,從加護病房到站在舞台上公益演出,身體的傷留下疤痕,心理的傷長出勇氣,她笑著說:「…當我今天比較有能量的時候,我就脫下外套,讓我的疤痕給大家看一下…」,思妤的人生經歷深深感動佳佳和淑雯,邀請大家一起來音樂療天室聊聊思妤的故事吧! Powered by Firstory Hosting
 
音樂療天室 一周年了耶!!! 回頭看看IG和FB上那51張主題圖,紮紮實實地週更,記錄著佳佳和淑雯的生活軌跡,音樂療天室讓兩個女孩嘗試了許多未知的可能,也帶領著兩個女孩認識許多人,下一個「 一周年」會在哪呢?邀請大家一起來「音樂療天室」聊聊吧! Powered by Firstory Hosting
 
這一個月的防疫生活,不知道大家都怎麼度過的呢?如果剛好有多餘的時間規劃學習,歡迎大家先來聽聽淑雯和佳佳參與線上課的經驗分享,再思考一下適合報名甚麼主題類型的線上課程吧! 相關課程:臺灣精神分析學會 Taiwan Psychoanalytic Association (psychoanalysis.org.tw) Powered by Firstory Hosting
 
恐懼的感覺有時候來自於知道的不夠,理解的太少,「早期療育」只是專業間溝通的名詞並非標籤,透過療育課程,創造適合孩子的成長空間,如果對「早療」服務還很陌生的大家,歡迎聽聽佳佳和淑雯聊早期療育吧! Powered by Firstory Hosting
 
Loading …

Skrócona instrukcja obsługi

Google login Twitter login Classic login